Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is 6.91% vs 46.68% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is 31.23% vs -25.80% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is 8.96% vs 46.03% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is -16.68% vs 264.85% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
Compare Quarterly Results Of ERIS Lifescience With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 2.51% vs 9.60% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 6.91% vs 46.68% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 1.86% vs 25.74% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 31.23% vs -25.80% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is 4.16% vs 9.64% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 8.96% vs 46.03% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 1.79% vs -10.32% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -16.68% vs 264.85% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






